Preferred Label : teprotumumab;

Obsolete resource : false;

MeSH note : a fully human IgG1 type monoclonal antibody directed against the human insulin-like growth factor-I receptor;

CISMeF synonym : R 1507; teprotumumab-trbw;

MeSH hyponym : R1507; R-1507; R-1507 monoclonal antibody; RO-4858696000; RO-4858696; RO4858696-000; RO4858696; RV001;

Is substance : O;

UNII : Y64GQ0KC0A;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://ansm.sante.fr/tableau-acces-derogatoire/tepezza
2025
false
false
false
France
French
summary of product characteristics
guidelines for drug use
insurance, health, reimbursement
tepezza
teprotumumab
teprotumumab
graves ophthalmopathy
graves disease
myxedema
infusions, intravenous
technical report

---
https://www.has-sante.fr/jcms/p_3592956/fr/tepezza-teprotumumab-ophtalmopathie-basedowienne
2025
false
false
false
France
evaluation of the transparency committee
graves ophthalmopathy
tepezza
teprotumumab

---
Nous contacter.
27/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.